# Grayscale Ethereum Staking Mini ETF: financial statements, quarterly

ETH · NYSE · CIK 2020455 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eth.md) · [Financials](/companies/eth/financials.md) · [Filings](/companies/eth/filings.md) · [Insiders](/companies/eth/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/eth/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2025 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [(290)](/filings/0001193125-25-266931.md) | [(717)](/filings/0001193125-26-214599.md) | [329](/filings/0002020455-26-000016.md) | [932](/filings/0001193125-25-266931.md) | [(861) d](/filings/0001193125-26-071961.md) | [(681)](/filings/0001193125-26-214599.md) | [(459)](/filings/0002020455-26-000016.md) |

- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q2 FY2025 (2024-06-30) | Q3 FY2025 (2024-09-30) | FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0000950170-24-102092.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [0.1](/filings/0000950170-24-102092.md) | [1,015](/filings/0000950170-24-120129.md) | [1,573](/filings/0001193125-26-071961.md) | [834](/filings/0000950170-25-062747.md) | [1,330](/filings/0000950170-25-101409.md) | [3,002](/filings/0001193125-25-266931.md) | [2,181](/filings/0002020455-26-000016.md) | [1,805](/filings/0001193125-26-214599.md) | [1,349](/filings/0002020455-26-000016.md) |
| Total liabilities | $m | [0.0](/filings/0000950170-24-102092.md) | [0.0](/filings/0000950170-24-120129.md) | [0.0](/filings/0001193125-26-071961.md) | [0.0](/filings/0000950170-25-062747.md) | [0.0](/filings/0000950170-25-101409.md) | [0.0](/filings/0001193125-25-266931.md) | [0.2](/filings/0002020455-26-000016.md) | [0.0](/filings/0001193125-26-214599.md) | [0.0](/filings/0002020455-26-000016.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities

## Cash flow

| Line item | Unit | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [20.7](/filings/0000950170-25-062747.md) | [0.0 d](/filings/0000950170-25-101409.md) | [(904) d](/filings/0001193125-25-266931.md) | [(45.2) d](/filings/0001193125-26-071961.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 88,040,788 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0002020455-26-000016.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.